Not Medicare Enrolled

Dr. Penny Chow, MD

Psychiatry · Sugar Land, TX
Low-engagement
52 SUGAR CREEK CENTER BLVD STE 225, Sugar Land, TX 77478
2814946222
In practice since 2007 (19 years)
NPI: 1336270107 verify on NPPES ↗
Moderate
DATA COVERAGE
Data in 2 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Chow from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Chow? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Chow

Dr. Penny Chow is a psychiatry specialist in Sugar Land, TX, with 19 years of NPI registration.

Between the years covered by Open Payments, Dr. Chow received a total of $6,601 from 30 pharmaceutical and/or device companies across 314 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in psychiatry. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Chow is Moderate — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice $6,601 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$6,601
Total received (2018-2024)
Avg $943/year across 7 years
Top 10% in TX for psychiatry
30
Companies
314
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,601 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$562
2023
$865
2022
$672
2021
$884
2020
$985
2019
$1,436
2018
$1,196

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Teva Pharmaceuticals USA, Inc.
$643
Allergan Inc.
$618
Otsuka America Pharmaceutical, Inc.
$580
Takeda Pharmaceuticals U.S.A., Inc.
$547
ABBVIE INC.
$532
Bausch Health US, LLC
$456
Sunovion Pharmaceuticals Inc.
$424
Janssen Pharmaceuticals, Inc
$409
AbbVie Inc.
$357
Lundbeck LLC
$282
Allergan, Inc.
$277
Axsome Therapeutics, Inc.
$236
Corium, LLC
$222
JAZZ PHARMACEUTICALS INC.
$174
Avanir Pharmaceuticals, Inc.
$108
Vanda Pharmaceuticals Inc.
$98
Shire North American Group Inc
$98
Ironshore Pharmaceuticals Inc.
$78
Neurocrine Biosciences, Inc.
$75
Neos Therapeutics, LP
$74
Noven Therapeutics, LLC
$62
Indivior Inc.
$57
Alkermes, Inc.
$42
Eisai Inc.
$41
Adlon Therapeutics L.P.
$32
Tris Pharma Inc
$25
Medtronic Vascular, Inc.
$18
Jazz Pharmaceuticals Inc.
$14
Vertical Pharmaceuticals, LLC
$12
Merck Sharp & Dohme Corporation
$11
Top 3 companies account for 27.9% of total payments
Associated products mentioned in payments ›
ABILIFY MAINTENA · ADHANSIA XR · APLENZIN · ARISTADA · AUSTEDO · AZSTARYS · Adzenys XR-ODT · Austedo XR · Auvelity · Azstarys · BELSOMRA · BRINTELLIX · Dayvigo · Dyanavel XR · FANAPT · HETLIOZ · INGREZZA · INVEGA SUSTENNA · INVEGA TRINZA · JORNAY PM · Jornay PM 20mg capsules (Bottle of 100) · LATUDA · MYDAYIS · NUEDEXTA · Nuedexta · PERSERIS · RELEXXII · REXULTI · SEEQ · SPRAVATO · SUNOSI · Secuado · TRINTELLIX · Trintellix · VRAYLAR · VYVANSE · WELLBUTRIN · WELLBUTRIN XL · Xelstrym
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 10% for psychiatry in TX.

Looking for a psychiatry specialist in Sugar Land?
Compare psychiatrists in the Sugar Land area by procedure volume, costs, and industry payment transparency.
Browse psychiatrists nearby

Geographic Context

Psychiatrists within 10 mi
713
Per 100K population
82.9
County median income
$113,409
Nearest hospital
ST LUKE'S SUGAR LAND HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment — Not enrolled N/A
Practice Data — No data N/A
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 2 of 4 available federal datasets, with a Data Coverage level of Moderate. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Chow is a psychiatry specialist, with low-engagement industry engagement in the top 10% of TX peers, with 19 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Chow receive payments from pharmaceutical companies?
Yes. Dr. Chow received a total of $6,601 from 30 companies across 314 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently Moderate for Dr. Chow) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →